Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 54
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05046431 | Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis | ||
| NCT05848466 | Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients | ||
| NCT04728360 | Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis | ||
| NCT03606876 | Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects | ||
| NCT05879627 | To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors | ||
| NCT05767060 | BAT7104 Injection in Patients with Advanced Malignant Tumors. | ||
| NCT05141994 | Clinical Study on the Efficacy and Safety of BAT5906 Injection | ||
| NCT04151329 | A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor | ||
| NCT05439629 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration | ||
| NCT05865574 | A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection | ||
| NCT05180526 | Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV) | ||
| NCT04432766 | A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients | ||
| NCT04152148 | A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients | ||
| NCT06321068 | BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer | ||
| NCT05377944 | Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients | ||
| NCT04151212 | A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration | ||
| NCT05155722 | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors | ||
| NCT04711343 | Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects | ||
| NCT06341114 | A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors | ||
| NCT06044350 | A Clinical Trial of BAT4406F Injection in Patients with Neuromyelitis Optica Spectrum Disorders | ||
| NCT03830203 | Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate | ||
| NCT04135508 | A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira | ||
| NCT05518695 | Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects | ||
| NCT05968508 | A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects | ||
| NCT05109650 | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients | ||
| NCT06111196 | Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects | ||
| NCT06280196 | A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC | ||
| NCT05148325 | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors | ||
| NCT05332730 | A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® | ||
| NCT03030430 | Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects | ||
| NCT05620017 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection | ||
| NCT05200013 | BAT7104 in Patients With Advanced Solid Tumours | ||
| NCT03884517 | Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer | ||
| NCT06094179 | Evaluate the Safety, Tolerability of BAT6026 | ||
| NCT05405621 | Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009 | ||
| NCT05073484 | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients | ||
| NCT06123884 | BAT1308 Combined With Platinum-Based Chemotherapy± Bevacizumab For PDL1-Positive (CPS ≥1) Cervical Cancer | ||
| NCT05803187 | Clinical Study of Stage IV Psoriasis in Children With Geleli | ||
| NCT06545617 | A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer | ||
| NCT05414136 | Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 | ||
| NCT06139536 | Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients | ||
| NCT06376136 | A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors | ||
| NCT04152759 | Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects | ||
| NCT04772105 | Clinical Study of the Safety and Efficacy of BAT5906 Injection | ||
| NCT05576454 | Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects | ||
| NCT04185649 | The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT05120375 | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China | ||
| NCT04146285 | A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders | ||
| NCT05378737 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection | ||
| NCT04371185 | Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects |
